Results
246
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
246 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$139.26 | -4.2% | 36.3% | US$43.6b | US$152.42 | PE72.7x | E33.4% | 2.7% | Diversified Financials | ||
SRPT | US$143.94 | -1.4% | 40.4% | US$13.6b | US$198.28 | PE805.2x | E39.4% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$107.27 | -3.9% | 136.2% | US$2.6t | US$139.72 | PE61.9x | E23.2% | 0.04% | Semiconductors | ||
NU | US$10.92 | -10.6% | 39.3% | US$52.3b | US$13.68 | PB7.7x | E27.4% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BX | US$133.05 | -5.6% | 28.0% | US$162.5b | US$134.11 | PE51.1x | E26.1% | 2.5% | Diversified Financials | ||
PDD | US$127.41 | -0.1% | 48.8% | US$176.9b | US$207.40 | PE15.9x | E21.6% | n/a | Retail | ||
SMCI | US$624.65 | -10.5% | 76.8% | US$36.6b | US$1,014.25 | PE34.9x | E39.0% | n/a | Tech | ||
CG | US$44.23 | -7.0% | 34.4% | US$15.9b | US$48.30 | PS7.2x | E23.6% | 3.2% | Diversified Financials | ||
OWL | US$16.26 | -16.0% | 32.3% | US$23.8b | US$20.41 | PE99x | E89.8% | 4.4% | Diversified Financials | ||
SYM | US$23.70 | -33.5% | -54.8% | US$13.9b | US$42.93 | PS1.5x | E111.0% | n/a | Capital Goods | ||
PTC | US$172.05 | -2.9% | 20.4% | US$20.7b | US$200.89 | PE70x | E24.0% | n/a | Software | ||
VRT | US$69.46 | -10.9% | 94.5% | US$26.1b | US$102.80 | PE52.2x | E29.9% | 0.1% | Capital Goods | ||
TER | US$117.27 | -8.3% | 7.7% | US$19.1b | US$145.63 | PE38.6x | E22.3% | 0.4% | Semiconductors | ||
SPOT | US$330.85 | 2.2% | 133.0% | US$66.4b | US$383.37 | PE130.6x | E29.5% | n/a | Media | ||
NTNX | US$47.23 | -5.6% | 57.1% | US$11.6b | US$74.54 | PS5.6x | E82.7% | n/a | Software | ||
ALNY | US$272.05 | 15.1% | 47.6% | US$34.9b | US$274.43 | PS14.9x | E65.3% | n/a | Pharmaceuticals & Biotech | ||
ZS | US$169.52 | -6.4% | 16.6% | US$25.6b | US$230.08 | PS12.6x | E44.4% | n/a | Software | ||
RYAN | US$68.57 | 14.1% | 54.7% | US$17.9b | US$64.08 | PE105.2x | E53.4% | 0.6% | Insurance | ||
VIK | US$32.93 | -6.8% | n/a | US$14.5b | US$36.27 | PS3x | E90.6% | n/a | Consumer Services | ||
MPWR | US$795.76 | -3.8% | 46.9% | US$38.8b | US$917.54 | PE94.4x | E23.1% | 0.6% | Semiconductors | ||
HUBS | US$465.66 | -6.6% | -5.8% | US$23.7b | US$642.31 | PS10.4x | E59.6% | n/a | Software | ||
CRWD | US$217.89 | -15.8% | 44.3% | US$53.0b | US$358.37 | PE402.8x | E35.2% | n/a | Software | ||
ARM | US$113.45 | -19.8% | n/a | US$118.9b | US$134.35 | PE280.4x | E32.0% | n/a | Semiconductors |